Sheel Biotech Limited (SBL) is engaged in growing, developing, processing, and supplying plants for field crops, fruits, vegetables, and ornamentals using tissue culture and organic farming techniques.
The company’s offerings include:
- Tissue culture plants for large-scale cultivation of disease-free, high-yield crops.
- Greenhouse manufacturing & maintenance to support modern protected farming.
- Farmer services & training through Farmer Producer Organizations (FPOs).
- Green landscaping projects for government and private clients.
SBL also operates an R&D laboratory recognized by the Department of Biotechnology (DBT), Government of India, with an annual production capacity of 10 million planting materials. Its Manesar facility is among the largest in Northern India.
Over the years, the company has expanded into importing tulip, lilium, orchids, gladiolus, and alstroemeria, further strengthening its portfolio in floriculture.
With ISO certifications (ISO 9001:2015, ISO 14001:2015 & ISO 45001:2018) and a team of industry experts in biotechnology, horticulture, and greenhouse management, Sheel Biotech serves a wide spectrum of customers—from farmers to institutional buyers—while promoting sustainable agricultural practices .
As of September 30, 2024, the Company has 160 permanent employees on its payroll.
Sheel Biotech IPO – Details
| IPO Opening Date | 30 September 2025 |
| IPO Closing Date | 03 October 2025 |
| Issue Type | Bookbuilding IPO |
| Issue Size | Total Issue: 54,00,000 Shares Worth ₹34.02 Crore Fresh Issue: 54,00,000 Shares Worth ₹34.02 Crore |
| Face Value | ₹10 per equity share |
| IPO Price | ₹59 to ₹63 per share |
| Market Lot | 2000 Shares |
| Min Order | 2000 Shares [ 1 Lot ] |
| Listing At | NSE SME |
| Registrar | Skyline Financial Services Pvt.Ltd. |
| QIB Shares Offered | 50% |
| NII Shares Offered | 15% |
| Retail Shares Offered | 35% |
Sheel Biotech IPO – Date Schedule
| IPO Open Date | 30 September 2025 |
| IPO Close Date | 03 October 2025 |
| Basis of Allotment | 06 October 2025 |
| Initiation of Refund | 07 October 2025 |
| Credit of Shares to Demat | 07 October 2025 |
| IPO Listing Date | 08 October 2025 |
| Cut-off time for UPI mandate confirmation | 5 PM on October 03, 2025 |
Sheel Biotech IPO – Lots Size & Price
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 2 | 4,000 | ₹2,52,000 |
| Retail (Max) | 2 | 4,000 | ₹2,52,000 |
| S-HNI (Min) | 3 | 6,000 | ₹3,78,000 |
| S-HNI (Max) | 7 | 14,000 | ₹8,82,000 |
| B-HNI (Min) | 8 | 16,000 | ₹10,08,000 |
Competitive Strength
- Skilled in biotechnology, organic farming, and greenhouse management.
- Offers a wide range of products across agriculture, floriculture, and horticulture.
- Eco-friendly practices and a focus on organic, sustainable farming.
Company Promoters
- Dr. Satya Narayan Chandak
- Mr. Sanjay Chandak
- Mr. Divye Chandak
- Mrs. Mini Chadha
- M/s Satya Narayan Chandak (HUF)
- M/s Sanjay Chandak (HUF)
- M/s Sumeet Chandak (HUF)
Company Financials
| Period | Total Revenue | Total Expense | Profit After Tax | Total Borrowings |
|---|---|---|---|---|
| 31 March 2023 | ₹80.19 Cr | ₹73.82 Cr | ₹5.08 Cr | ₹19.17 Cr |
| 31 March 2024 | ₹92.55 Cr | ₹80.29 Cr | ₹10.47 Cr | ₹23.54 Cr |
| 31 March 2025 | ₹102.27 Cr | ₹89.45 Cr | ₹10.64 Cr | ₹17.36 Cr |
Key Performance Indicator
| KPI | Values |
|---|---|
| ROE | 13.59% |
| ROCE | 16.34% |
| Debt/Equity | 0.32 |
| RoNW | 13.59% |
| EBITDA Margin | 14.71 |
| Price to Book Value | 1.26 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (₹) | 7.03 | 1.43 |
| P/E (x) | 8.96 | 44.07 |
Object Of The Issue
| Objects of the Issue | Expected Amount (in Crore) |
|---|---|
| Capital Expenditure Requirement. | ₹9.12 |
| Working Capital Requirements. | ₹15.88 |
| General Corporate Purposes. | – |
✅Strengths
- Long track record in tissue culture, greenhouses & organic farming.
- Wide product mix with R&D-backed capacity of 10M plants/year.
- ISO-certified, financially stable with low debt & healthy growth.
⚠️Risks
- Ongoing litigations and customer disputes.
- High dependence on agri policies, climate & subsidies.
- Working capital heavy with large receivables; strong competition.
Sheel Biotech IPO Promoter Holding
| Pre Issue Share Holding | 96.99% |
| Post Issue Share Holding | 71.26% |
Sheel Biotech IPO Prospectus
Company Contact Information
| Sheel Biotech Ltd. 8 Balaji Estates, 2nd Floor, Block-C, Guru Ravidas Marg Kalkaji South Delhi, New Delhi, 110019 Phone: +91 88511 – 8980 Email: compliance@sheelbiotech.com Website: http://www.sheelbiotech.com/ |
Sheel Biotech IPO Registrar
| Skyline Financial Services Pvt.Ltd. Phone: 02228511022 Email: compliances@skylinerta.com Website: https://www.skylinerta.com/ipo.php |
Sheel Biotech IPO Lead Manager(s)
| 1. Narnolia Financial Services Ltd. |
Sheel Biotech IPO FAQ
| What is Sheel Biotech IPO? Sheel Biotech IPO is an SME IPO. The issue is priced at ₹59 to ₹63 per equity share. The IPO is to be listed on NSE SME. |
| When Sheel Biotech IPO will open? The IPO is to open on 30 September 2025 for QIB, NII, and Retail Investors. |
| What is Sheel Biotech IPO Investors Portion? The investors’ portion for QIB – 50%, NII – 15%, and Retail – 35%. |
| What is the Sheel Biotech IPO Size? Sheel Biotech IPO size is ₹34.02 Crore. |
| What is Sheel Biotech IPO Minimum and Maximum Lot Size for Retail? The minimum bid is 4,000 Shares with ₹2,52,000 amount, while the maximum bid is 4,000 Shares with ₹2,52,000. |
| What is the Sheel Biotech IPO Allotment Date? Sheel Biotech IPO allotment date is 06 October 2025. |
| What is the Sheel Biotech IPO Listing Date? Sheel Biotech IPO listing date is 08 October 2025. The IPO is to be listed on the NSE SME. |
